Abbott Laboratories (NYSE:ABT) under-valued by 14%
Website | https://www.abbott.com |
Sector | Healthcare |
Industry | Medical Devices |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $206,786,297,856 |
Beta | 0.677005 |
Average Volume | $5,018,203 |
Last Dividend | 1.62% |
Price on Nov 1, 2022 | $99.31 |
Autochartist™ Valuation | $112.78 |
Conclusion |
14% under-valued |
Download Report |